Cargando…

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines

Since the discovery of the first virus-like particle (VLP) derived from hepatitis B virus in 1980 (1), the field has expanded substantially. Besides successful use of VLPs as safe autologous virus-targeting vaccines, the powerful immunogenicity of VLPs has been also harnessed to generate immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Ariane C., Flace, Anna, Saudan, Philippe, Zabel, Franziska, Cabral-Miranda, Gustavo, Turabi, Aadil El, Manolova, Vania, Bachmann, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337491/ https://www.ncbi.nlm.nih.gov/pubmed/28321220 http://dx.doi.org/10.3389/fimmu.2017.00226

Ejemplares similares

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
por: Doucet, Marika, et al.
Publicado: (2017)

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017)

Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles
por: Jegerlehner, Andrea, et al.
Publicado: (2013)

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
por: C. Gomes, Ariane, et al.
Publicado: (2019)

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia
por: Nyffenegger, Naja, et al.
Publicado: (2021)

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
por: Zeltins, Andris, et al.
Publicado: (2017)

Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of b-thalassemia with blood transfusions
por: Kalleda, Natarajaswamy, et al.
Publicado: (2023)

Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
por: Tissot, Alain C., et al.
Publicado: (2010)

The Prospects of an Active Vaccine Against Asthma Targeting IL-5
por: Bachmann, Martin F., et al.
Publicado: (2018)

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
por: Mohsen, Mona O., et al.
Publicado: (2019)

Particle physics contribution to the elimination of nuclear waste
por: Revol, Jean Pierre Charles
Publicado: (1999)

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
por: Schmitz, Nicole, et al.
Publicado: (2009)

P1510: VAMIFEPORT PREVENTED THE FORMATION OF NON-TRANSFERRIN-BOUND IRON IN A MOUSE MODEL OF ΒETA-THALASSEMIA WITH BLOOD TRANSFUSIONS
por: Kalleda, N., et al.
Publicado: (2022)

The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease
por: Nyffenegger, Naja, et al.
Publicado: (2022)

Grazing of particle-associated bacteria—an elimination of the non-viable fraction
por: Gonsalves, Maria-Judith, et al.
Publicado: (2016)

Plant virus particles with various shapes as potential adjuvants
por: Evtushenko, Ekaterina A., et al.
Publicado: (2020)

Evaluation of Microflow Digital Imaging Particle Analysis for Sub-Visible Particles Formulated with an Opaque Vaccine Adjuvant
por: Frahm, Grant E., et al.
Publicado: (2016)

Microcrystalline Tyrosine (MCT(®)): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017)

Relationship of Time-Activity-Adjusted Particle Number Concentration with Blood Pressure
por: Corlin, Laura, et al.
Publicado: (2018)

Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine
por: Feng, Huapeng, et al.
Publicado: (2020)

The adjuvant effect of bacterium-like particles depends on the route of administration
por: Sudo, Haruka, et al.
Publicado: (2023)

Determining the appropriate number of particles on a filter to allow small microplastics to be analyzed by microscopy
por: Xu, Haodong, et al.
Publicado: (2022)

Eliminating effects of particle adsorption to the air/water interface in single-particle cryo-electron microscopy: Bacterial RNA polymerase and CHAPSO
por: Chen, James, et al.
Publicado: (2019)

Continuous Production of Prions after Infectious Particles Are Eliminated: Implications for Alzheimer’s Disease
por: Miyazawa, Kohtaro, et al.
Publicado: (2012)

On Iron Metabolism and Its Regulation
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2021)

Effect of time-activity adjustment on exposure assessment for traffic-related ultrafine particles
por: Lane, Kevin J, et al.
Publicado: (2015)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
por: Visciano, Maria Luisa, et al.
Publicado: (2012)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Nanometric Virus-Like Particles: Key Tools for Vaccine and Adjuvant Technology
por: Bardi, Giuseppe
Publicado: (2020)

Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020)

Tandem Fusion of Hepatitis B Core Antigen Allows Assembly of Virus-Like Particles in Bacteria and Plants with Enhanced Capacity to Accommodate Foreign Proteins
por: Peyret, Hadrien, et al.
Publicado: (2015)

An enhanced characterization process for the elimination of very low level radioactive waste in particle accelerators
por: Frosio, Thomas, et al.
Publicado: (2020)

A cautionary note on the appropriateness of using a linkage resource for an association study
por: Allen-Brady, Kristina, et al.
Publicado: (2003)

Multipacting Simulations of Tuner-adjustable waveguide coupler (TaCo) with CST Particle Studio®
por: Shafqat, N, et al.
Publicado: (2014)

The allergy adjuvant effect of particles – genetic factors influence antibody and cytokine responses
por: Nygaard, Unni Cecilie, et al.
Publicado: (2005)

Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition
por: Eidi, Housam, et al.
Publicado: (2015)

Virus-like particle vaccinology, from bench to bedside
por: Mohsen, Mona O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oh9fogiei64q59dtovhagdk158